FWP
Income statement / Annual
Last year (2021), Forward Pharma A/S's total revenue was -$188.00 K,
and the percentage change from the previous year is not available.
In 2021, Forward Pharma A/S's net income was $90.00 K.
See Forward Pharma A/S,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
FY-2013
|
FY-2012
|
| Period Ended |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
12/31/2013 |
12/31/2012 |
| Operating Revenue |
-$188.00 K |
$0.00 |
$0.00 |
$0.00 |
$1.25 B |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$25.00 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit |
-$188.00 K
|
$0.00
|
$0.00
|
$0.00
|
$1.23 B
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit Ratio |
1
|
0
|
0
|
0
|
0.98
|
0
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$226.00 K
|
$327.00 K
|
$1.05 M
|
$2.75 M
|
$20.50 M
|
$41.05 M
|
$33.73 M
|
$10.55 M
|
$8.02 M
|
$4.45 M
|
| General & Administrative Expenses |
$3.65 M
|
$3.06 M
|
$4.23 M
|
$9.54 M
|
$17.11 M
|
$14.38 M
|
$15.85 M
|
$9.15 M
|
$1.01 M
|
$928.00 K
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$3.65 M
|
$3.06 M
|
$4.23 M
|
$9.54 M
|
$17.11 M
|
$14.38 M
|
$15.85 M
|
$9.15 M
|
$1.01 M
|
$928.00 K
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$3.87 M
|
$3.39 M
|
$5.28 M
|
$12.28 M
|
$37.60 M
|
$55.43 M
|
$49.58 M
|
$19.70 M
|
$9.03 M
|
$5.37 M
|
| Cost And Expenses |
$3.87 M
|
$3.39 M
|
$5.28 M
|
$12.28 M
|
$62.60 M
|
$55.43 M
|
$49.58 M
|
$19.70 M
|
$9.03 M
|
$5.37 M
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$227.00 K
|
$389.00 K
|
$438.00 K
|
$63.00 K
|
$0.00
|
$0.00
|
| Interest Expense |
-$1.98 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$416.00 K
|
$75.00 K
|
$32.00 K
|
| Depreciation & Amortization |
$1.98 M
|
-$3.06 M
|
$1.00 K
|
$4.00 K
|
$227.00 K
|
$109.00 K
|
$37.00 K
|
$3.00 K
|
$4.00 K
|
$2.00 K
|
| EBITDA |
-$1.89 M |
-$6.45 M |
-$4.22 M |
-$8.92 M |
$1.18 B |
-$54.43 M |
-$37.30 M |
-$18.85 M |
-$15.71 M |
-$22.45 M |
| EBITDA Ratio |
10.06
|
0
|
0
|
0
|
0.95
|
0
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
20.61
|
0
|
0
|
0
|
0.95
|
0
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
$1.98 M
|
-$3.06 M
|
$1.06 M
|
$3.36 M
|
-$2.91 M
|
$895.00 K
|
$12.24 M
|
$435.00 K
|
-$6.76 M
|
-$17.11 M
|
| Income Before Tax |
-$1.89 M
|
-$6.45 M
|
-$4.22 M
|
-$8.93 M
|
$1.18 B
|
-$54.54 M
|
-$37.34 M
|
-$19.27 M
|
-$15.79 M
|
-$22.48 M
|
| Income Before Tax Ratio |
10.06
|
0
|
0
|
0
|
0.95
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
-$1.98 M
|
$0.00
|
$0.00
|
-$204.00 K
|
$267.40 M
|
-$21.20 M
|
-$336.00 K
|
-$250.00 K
|
-$96.00 K
|
$0.00
|
| Net Income |
$90.00 K
|
-$6.45 M
|
-$4.22 M
|
-$8.72 M
|
$917.09 M
|
-$33.34 M
|
-$37.00 M
|
-$19.02 M
|
-$15.70 M
|
-$22.48 M
|
| Net Income Ratio |
-0.48
|
0
|
0
|
0
|
0.73
|
0
|
0
|
0
|
0
|
0
|
| EPS |
0.0009 |
-0.0672 |
-0.0444 |
-0.0921 |
9.65 |
-0.35 |
-0.4 |
-0.28 |
-0.17 |
-0.25 |
| EPS Diluted |
0.0009 |
-0.0672 |
-0.0444 |
-0.0921 |
9.2 |
-0.35 |
-0.4 |
-0.28 |
-0.17 |
-0.25 |
| Weighted Average Shares Out |
$97.76 M
|
$96.00 M
|
$95.07 M
|
$94.67 M
|
$95.03 M
|
$94.02 M
|
$93.49 M
|
$68.98 M
|
$91.63 M
|
$91.63 M
|
| Weighted Average Shares Out Diluted |
$97.76 M
|
$96.00 M
|
$95.07 M
|
$94.67 M
|
$99.74 M
|
$94.02 M
|
$93.49 M
|
$68.98 M
|
$91.63 M
|
$91.63 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
